Literature DB >> 11979445

Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery.

Smadar Schreiber1, Shimon Gross, Alex Brandis, Alon Harmelin, Varda Rosenbach-Belkin, Avigdor Scherz, Yoram Salomon.   

Abstract

Photodynamic therapy (PDT), locally applied to solid C6 rat glioma tumors in the foot of CD1 nude mice, eradicated the primary tumor and also decreased the rate of groin and lung metastases. Pd-Bacteriopheophorbide (Pd-Bpheid), a novel photosensitizer synthesized in our laboratory, was used in our study. The primary lesion in the hind leg was treated by an i.v. injection of 5 mg/kg of Pd-Bpheid and immediate illumination (650-800 nm, 360 J/cm(2)). This protocol and the surgical amputation of the leg were compared for local and metastasis responses. Following PDT, hemorrhage, inflammation with tumor necrosis and flattening were observed and histologically verified in the photodynamically treated tumor. Whereas local tumor control rates were up to 64% following PDT, in surgically treated animals, local tumor control was absolute. The rates of metastases in the groin and the lungs were at least 12-fold lower in the photodynamically treated animals compared with untreated or surgery-treated groups. The overall cure rates after PDT or surgery were 36% and 6%, respectively, at 8 weeks. These findings suggest that local PDT with Pd-Bpheid, which acts primarily on the tumor vasculature, efficiently eradicates the solid C6 tumors. In addition, the local PDT of the primary lesion has beneficial therapeutic effects on remote C6 metastasis, which is not obtained with surgery. It is therefore suggested, that although surgery is highly efficient for the immediate removal of the primary tumor, it lacks such systemic, therapeutic effects on distant metastases. Pd-Bpheid-PDT may thus offer a potentially superior curative therapy for C6 glioma tumors in the limb by eradicating the target tumor and by reducing the rate of metastasis in the groin and lung, possibly due to innate immunity. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979445     DOI: 10.1002/ijc.10299

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Synthesis, spectroscopic, and in vitro photosensitizing efficacy of ketobacteriochlorins derived from ring-B and ring-D reduced chlorins via pinacol-pinacolone rearrangement.

Authors:  Penny Joshi; Manivannan Ethirajan; Lalit N Goswami; Avinash Srivatsan; Joseph R Missert; Ravindra K Pandey
Journal:  J Org Chem       Date:  2011-10-05       Impact factor: 4.354

2.  The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.

Authors:  Zheng Huang; Qun Chen; Kenneth C Dole; Al B Barqawi; Yang K Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel
Journal:  Photochem Photobiol Sci       Date:  2007-08-22       Impact factor: 3.982

Review 3.  Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.

Authors:  Anahita Ebrahimpour; Mohammad Sarfi; Setareh Rezatabar; Sadra Samavarchi Tehrani
Journal:  Mol Cell Biochem       Date:  2021-02-13       Impact factor: 3.396

4.  Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Authors:  Adriana Casas; Gabriela Di Venosa; Silvia Vanzulli; Christian Perotti; Leandro Mamome; Lorena Rodriguez; Marina Simian; Angeles Juarranz; Osvaldo Pontiggia; Tayyaba Hasan; Alcira Batlle
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

5.  Vascular targeted photodynamic therapy for localized prostate cancer.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2008

Review 6.  Enhancement of anti-tumor immunity by photodynamic therapy.

Authors:  Sandra O Gollnick; Craig M Brackett
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

7.  Bypass of tumor drug resistance by antivascular therapy.

Authors:  Dina Preise; Ohad Mazor; Natalia Koudinova; Mordechai Liscovitch; Avigdor Scherz; Yoram Salomon
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

Review 8.  The prostate cancer focal therapy.

Authors:  Filippo Pesapane; Francesca Patella; Enrico Maria Fumarola; Edoardo Zanchetta; Chiara Floridi; Gianpaolo Carrafiello; Chloë Standaert
Journal:  Gland Surg       Date:  2018-04

9.  Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.

Authors:  Vicki Plaks; Natalia Koudinova; Uri Nevo; Jehonathan H Pinthus; Hannah Kanety; Zelig Eshhar; Jacob Ramon; Avigdor Scherz; Michal Neeman; Yoram Salomon
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

10.  Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.

Authors:  Scott E Eggener; Jonathan A Coleman
Journal:  ScientificWorldJournal       Date:  2008-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.